How We Manage Hyperferritinemic Sepsis-Related Multiple Organ Dysfunction Syndrome/Macrophage Activation Syndrome/Secondary Hemophagocytic Lymphohistiocytosis Histiocytosis. - Wikidata - wikimedia - TriplyDB

How We Manage Hyperferritinemic Sepsis-Related Multiple Organ Dysfunction Syndrome/Macrophage Activation Syndrome/Secondary Hemophagocytic Lymphohistiocytosis Histiocytosis.

How We Manage Hyperferritinemic Sepsis-Related Multiple Organ Dysfunction Syndrome/Macrophage Activation Syndrome/Secondary Hemophagocytic Lymphohistiocytosis Histiocytosis.

http://www.wikidata.org/entity/Q37387929

about

Hemophagocytic lymphohistiocytosis: an update for nephrologists.Cytokine Release Syndrome After Chimeric Antigen Receptor T Cell Therapy for Acute Lymphoblastic Leukemia.Interleukin 1 Receptor Antagonist Anakinra, Intravenous Immunoglobulin, and Corticosteroids in the Management of Critically Ill Adult Patients With Hemophagocytic Lymphohistiocytosis.

P2860

Q38813217-A69187E0-0188-4BCA-897A-01E53C12A1AC Q39385892-24BA8E33-9B8B-4457-8DB1-F10BE6FED569 Q39599766-0D8FEE87-6CFB-496F-ABDB-BB5345EBA9E9

P2860

How We Manage Hyperferritinemic Sepsis-Related Multiple Organ Dysfunction Syndrome/Macrophage Activation Syndrome/Secondary Hemophagocytic Lymphohistiocytosis Histiocytosis.

http://www.wikidata.org/entity/Q37387929

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on July 2015

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

How We Manage Hyperferritinemi ...... hohistiocytosis Histiocytosis.

@en

How We Manage Hyperferritinemi ...... hohistiocytosis Histiocytosis.

@nl

type

label

How We Manage Hyperferritinemi ...... hohistiocytosis Histiocytosis.

@en

How We Manage Hyperferritinemi ...... hohistiocytosis Histiocytosis.

@nl

prefLabel

How We Manage Hyperferritinemi ...... hohistiocytosis Histiocytosis.

@en

How We Manage Hyperferritinemi ...... hohistiocytosis Histiocytosis.

@nl

P1433

Q37387929-3A9CF8D3-274C-4E09-8244-AC252E6AC828

P1476

Q37387929-ECACB42A-44E0-4257-9DE7-0A28D9CAB450

P2093

Q37387929-457620AC-BDE8-4F1C-B1B5-45D6FE7A2FDE

Q37387929-499A884B-9152-478C-950D-3212DA71EF89

Q37387929-8CF0B4BE-42F2-43C6-A78E-DB81DAD3ECE4

P2860

Q37387929-00E68016-B2BE-416A-9345-9987700B2371

Q37387929-177B0245-37AD-4324-B748-414C98D4F7D8

Q37387929-22C28377-F1F1-48A3-9830-6FAFF303B297

Q37387929-3446FBDC-98BE-4F28-BCCD-269199365F3A

Q37387929-3EA944FC-9ACC-459F-9DF6-4E21E3432C84

Q37387929-46160D62-B18C-4255-9AC3-90EBFAF2028D

Q37387929-59203946-F2D0-47ED-8F84-B8CAEA18723A

Q37387929-6FD5FE1E-40A0-4354-A663-A33279C30D87

Q37387929-723AE578-5D89-4866-ACAF-9FB65E42F668

Q37387929-7CF3B7D3-38BC-41DF-9ED4-1CAC40AAFAF9

P304

Q37387929-A9465BF8-A040-45DB-BE85-784ACCCF1DE8

P31

Q37387929-97CC6332-5AE9-453F-8B5B-7B4F102A2B0F

P356

Q37387929-D5BF23EB-A2B0-4278-90BE-9261F9AC364F

P433

Q37387929-177D15BC-D566-4E81-A08E-7A9FBEC3AA95

P478

Q37387929-044C82CE-7188-4760-BBCE-A937D69C6EEA

P577

Q37387929-29F59700-73F3-48F8-8267-B6A0F8E7042F

P698

Q37387929-D1665331-CEF6-4103-8674-42DA1B401778

P921

Q37387929-4EF85F7C-5B14-4B73-AD97-05E28196DA57

Q37387929-BBAA0FA9-3B8F-4837-AB48-346BEF7D90B1

P932

Q37387929-928A0864-7E67-41D1-A165-29411D859DA2

P356

PCC.0000000000000460

P1433

Pediatric Critical Care Medicine

P1476

How We Manage Hyperferritinemi ...... hohistiocytosis Histiocytosis.

@en

P2093

Bradley S Podd

http://www.w3.org/2001/XMLSchema#string

Dennis W Simon

http://www.w3.org/2001/XMLSchema#string

Joseph A Carcillo

http://www.w3.org/2001/XMLSchema#string

P2860

Reactive haemophagocytic syndrome in children with inflammatory disorders. A retrospective study of 24 patients

Prognostic Factors and Long-Term Outcome in 52 Turkish Children With Hemophagocytic Lymphohistiocytosis.

Repeated TLR9 stimulation results in macrophage activation syndrome-like disease in mice.

Whole-exome sequencing reveals overlap between macrophage activation syndrome in systemic juvenile idiopathic arthritis and familial hemophagocytic lymphohistiocytosis

Chemoimmunotherapy for hemophagocytic lymphohistiocytosis: long-term results of the HLH-94 treatment protocol

Hyperferritinemia in the critically ill child with secondary hemophagocytic lymphohistiocytosis/sepsis/multiple organ dysfunction syndrome/macrophage activation syndrome: what is the treatment?

Ferritin functions as a proinflammatory cytokine via iron-independent protein kinase C zeta/nuclear factor kappaB-regulated signaling in rat hepatic stellate cells.

Mutated recombinant human heavy-chain ferritins and myelosuppression in vitro and in vivo: a link between ferritin ferroxidase activity and biological function.

A critical role of CpG motifs in a murine peritonitis model by their binding to highly expressed toll-like receptor-9 on liver NKT cells.

Clinical features, treatment, and outcome of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a multinational, multicenter study of 362 patients.

P304

598-600

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/PCC.0000000000000460

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P577

2015-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26154908

http://www.w3.org/2001/XMLSchema#string

P921

P932

5091295

http://www.w3.org/2001/XMLSchema#string